Business Is Booming At Genentech
Posted by Osagie K. Obasogie January 19, 2007
Biopolitical Times
Fourth-quarter financial reports are out, and it looks like Genentech's aggressive pricing of some of its drugs -- as if they are abstract widgets rather than medicines that people depend upon -- has paid off handsomely: profits have surged by 75%. Check out this post from November on why we should be paying more attention to this.